[go: up one dir, main page]

AU5828180A - Antithrombotic combination - Google Patents

Antithrombotic combination

Info

Publication number
AU5828180A
AU5828180A AU58281/80A AU5828180A AU5828180A AU 5828180 A AU5828180 A AU 5828180A AU 58281/80 A AU58281/80 A AU 58281/80A AU 5828180 A AU5828180 A AU 5828180A AU 5828180 A AU5828180 A AU 5828180A
Authority
AU
Australia
Prior art keywords
antithrombotic
combination
antithrombotic combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU58281/80A
Inventor
Alfred Sallmann
Alan M. White
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of AU5828180A publication Critical patent/AU5828180A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU58281/80A 1979-05-11 1980-05-09 Antithrombotic combination Abandoned AU5828180A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH441579 1979-05-11
CH4415795 1979-05-11

Publications (1)

Publication Number Publication Date
AU5828180A true AU5828180A (en) 1980-11-13

Family

ID=4275714

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58281/80A Abandoned AU5828180A (en) 1979-05-11 1980-05-09 Antithrombotic combination

Country Status (5)

Country Link
EP (1) EP0019586A1 (en)
JP (1) JPS55151512A (en)
AU (1) AU5828180A (en)
IL (1) IL60036A0 (en)
ZA (1) ZA802788B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7807690B2 (en) 2007-09-21 2010-10-05 Eisai R&D Management Co., Ltd. 2,3-dihydro-iminoisoindole derivatives
US7816522B2 (en) 2006-03-24 2010-10-19 Eisai Co., Ltd. Triazolone derivatives

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3237575A1 (en) * 1982-10-09 1984-04-12 Dr. Karl Thomae Gmbh, 7950 Biberach NEW ORAL MOPIDAMOL SHAPES
US20080132507A1 (en) * 2004-10-13 2008-06-05 Eisai R&D Management Co., Ltd. Hydrazide Derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2023415C3 (en) * 1970-05-13 1974-10-03 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz (beta-Phenylsulfinyl-ethyl) -malonic acid-NjN-miphenylhydrazide and its salts, process for its preparation and medicaments containing them
US3966923A (en) * 1972-06-05 1976-06-29 Pierre Fabre S.A. Medicaments intended for the prevention and treatment of ischemic disturbances
DE2735830A1 (en) * 1977-08-09 1979-03-01 Thomae Gmbh Dr K ANTITHROMBOTIC DRUG COMBINATION AND METHOD FOR THE PRODUCTION THEREOF

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7816522B2 (en) 2006-03-24 2010-10-19 Eisai Co., Ltd. Triazolone derivatives
US7928228B2 (en) 2006-03-24 2011-04-19 Eisai Co., Ltd. Triazolone derivatives
US8163787B2 (en) 2006-03-24 2012-04-24 Eisai R&D Management Co., Ltd. Triazolone derivatives
US7807690B2 (en) 2007-09-21 2010-10-05 Eisai R&D Management Co., Ltd. 2,3-dihydro-iminoisoindole derivatives

Also Published As

Publication number Publication date
EP0019586A1 (en) 1980-11-26
JPS55151512A (en) 1980-11-26
IL60036A0 (en) 1980-07-31
ZA802788B (en) 1981-01-28

Similar Documents

Publication Publication Date Title
AU548070B2 (en) Arylsulphonyls
AU532626B2 (en) Monacolink
AU541091B2 (en) Azolyloxy-carboxylic acid -oxy-amides
AU532783B2 (en) 4-aroyl-imazol-2-ones
AU537592B2 (en) Mercaptoacyldipeptides
AU5577580A (en) Breathalyser
AU533526B2 (en) Polyether-polyamines
AU529508B2 (en) 6-n-propyl-8alpha-methoxymethyl or -methylmercaptomethyl -ergolines
AU520911B2 (en) Connection piece
AU527992B2 (en) 9-aminoalkylfluorenes
AU528665B2 (en) Breathalyser
AU532763B2 (en) 8-aminoalkyl-4-alkylpsoralens
AU538025B2 (en) N-cyanoimidate
AU5537680A (en) Tetrahydrobenzothiazolylimidazolidinones
AU531811B2 (en) Thiazolylidene-oxo-propionitriles
AU532359B2 (en) 2-amino-3-benzoyl-phenylacetamides
AU536556B2 (en) Aldehyde-ethers
AU5689380A (en) Diphenylalkanoether
AU538686B2 (en) 1-substituted-2-pyrrolidinones
AU528075B2 (en) Z-aza-ergolines
AU541869B2 (en) 10-halo-e-homo eburnanes
AU535376B2 (en) N-oximinoalkyl-anilides
AU534662B2 (en) Azolyl-alkenols
AU5828180A (en) Antithrombotic combination
AU5703080A (en) 4-beta-substituted-2-azetidinones